3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
35
Myelodysplastic Syndromes
28
Precursor Cell Lymphoblastic Leukemia-Lymphoma
26
Hematologic Neoplasms
14
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
13
Lymphoma, Non-Hodgkin
12
Myeloproliferative Disorders
11
Lymphoma
11
Leukemia, Myelomonocytic, Chronic
11
Graft vs Host Disease
10
Primary Myelofibrosis
9
Leukemia
9
Hodgkin Disease
9
Leukemia, Lymphocytic, Chronic, B-Cell
7
Anemia, Refractory, with Excess of Blasts
7
Multiple Myeloma
6
Leukemia, Biphenotypic, Acute
6
Burkitt Lymphoma
5
Polycythemia Vera
4
Lymphoma, Follicular
4
Leukemia, Myeloid
4
Leukemia, Lymphoid
4
Anemia, Aplastic
4
Thrombocythemia, Essential
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Precancerous Conditions
3
Neoplasms, Plasma Cell
3
Neoplasms
3
Myelodysplastic-Myeloproliferative Diseases
3
Lymphoproliferative Disorders
3
Interventions
Magnetic Resonance Spectroscopy
7
X-Rays
6
Specimen Handling
6
Phantoms, Imaging
6
Nuclear Medicine Department, Hospital
5
Biopsy
5
ulixertinib
2
trametinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
dabrafenib
2
LY3023414
2
olaparib
1
etoposide phosphate
1
cobimetinib
1
Vemurafenib
1
Sirolimus
1
Pharmacogenomic Variants
1
Lenalidomide
1
Genetic Testing
1
Etoposide
1
Cyclophosphamide
1
Celecoxib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Histiocytosis, Langerhans-Cell
×
Tacrolimus
×
1 year
×
Clear all
No trials found.